The GSD NovaType Select assay family provides customers with the ability to specifically screen for mutations most concerning at a given time, and rapidly switch to or add other mutations when necessary. The GSD NovaType Select family of assays will be constantly updated when new variants arise to detect specific mutations.

GSD NovaType Select T478K has been designed for the detection of SARS-CoV-2 sequences carrying the mutation T478K, associated with the Delta variant. The GSD NovaType Select K417N/T allows for the detection of the mutations K417N and K417T, associated with variants Beta, Gamma and Delta (+). Finally, GSD NovaType Select E484K detects mutation E484K present for example in the variants Alpha + E484K, Beta, and Gamma. Together with NovaType Select L452R, the first reference launched for the identification of Delta, B.1.429/ B.1.427 and Kappa variants, the assays provide the opportunity to assemble a customised RT-PCR assay mutation panel from a selection of primers and probes.

The GSD NovaType Select range comprises a combination of the GSD NovaType Select Base SARS-CoV-2 assay and mutation specific GSD NovaType Select kits with mutant specific primer and probes. This allows for maximum flexibility to select and identify mutations of choice.

The test kits can be run with positive samples from validated SARS-CoV-2 RNA diagnostic RT-PCR methods, such as GSD NovaPrime® SARS-CoV-2 (COVID-19), across an array of specimen types, including nasal, nasopharyngeal and oropharyngeal.
 
For more information and online purchase option, please visit the product pages.